Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Evolent Health ( (EVH) ) has provided an update.
On December 5, 2025, Evolent Health LLC completed the transactions outlined in a Stock Purchase Agreement with Privia Management Company, LLC, initially announced on September 23, 2025. This transaction may have implications for Evolent Health’s strategic positioning and operational capabilities within the healthcare sector.
The most recent analyst rating on (EVH) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Evolent Health stock, see the EVH Stock Forecast page.
Spark’s Take on EVH Stock
According to Spark, TipRanks’ AI Analyst, EVH is a Neutral.
Evolent Health’s overall stock score is driven by significant financial challenges, including declining revenues and profitability issues. While the earnings call and corporate events highlight strategic growth and positive changes, the technical analysis and valuation reflect current market weaknesses. The company’s efforts to improve financial stability and strategic positioning are notable but have yet to translate into strong financial performance.
To see Spark’s full report on EVH stock, click here.
More about Evolent Health
Evolent Health operates in the healthcare industry, providing services related to healthcare delivery and payment solutions, with a focus on improving clinical and financial outcomes for healthcare providers and payers.
Average Trading Volume: 3,667,369
Technical Sentiment Signal: Sell
Current Market Cap: $439.7M
Learn more about EVH stock on TipRanks’ Stock Analysis page.